Slippages (over the intervention period) · infants
Skin care intervention showed no clear difference in slippages (over the intervention period) compared with standard skin care or no skin care intervention (low certainty).
1 finding from 1 review
Skin infection (over the intervention period) · infants
Skin care intervention probably leads to higher skin infection (over the intervention period) compared with standard skin care or no skin care intervention (moderate certainty).
1 finding from 1 review
Stinging/allergic reactions to moisturisers (over the intervention period) · infants
Skin care intervention showed no clear difference in stinging/allergic reactions to moisturisers (over the intervention… compared with standard skin care or no skin care intervention (low certainty).
1 finding from 1 review
Time to onset of eczema · infants
Skin care intervention showed no clear difference in time to onset of eczema compared with standard skin care or no skin care intervention (moderate certainty).
1 finding from 1 review
Parent report of immediate reaction to common food allergen (at 2 years) · infants
Skin care intervention showed no clear difference in parent report of immediate reaction to common food allergen (at 2… compared with standard skin care or no skin care intervention (low certainty).
1 finding from 1 review
Allergic sensitisation to a food allergen (at 1 to 3 years) · infants
Skin care intervention showed no clear difference in allergic sensitisation to a food allergen (at 1 to 3 years) compared with standard skin care or no skin care intervention (low certainty).
1 finding from 1 review
Intervention not reported
Outcomes ( · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
All‐cause mortality · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Non‐fatal MI · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Stroke · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Peripheral artery disease · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Type 2 diabetes · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Cardiovascular mortality (11.1 to 26 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention showed no clear difference in cardiovascular mortality (11.1 to 26 y) (low certainty).
1 finding from 1 review
HR 1 [0.95, 1.06]
203063 participants
Low
Intervention not reported
All‐cause mortality (11.1 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
It is very uncertain whether the intervention changes all‐cause mortality (11.1 y) (very low certainty).
1 finding from 1 review
HR 1 [0.99, 1.01]
159265 participants
Very low
Intervention not reported
Non‐fatal MI (26 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention showed no clear difference in non‐fatal MI (26 y) (low certainty).
1 finding from 1 review
HR 0.99 [0.89, 1.1]
43798 participants
Low
Intervention not reported
Stroke · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Peripheral artery disease · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Type 2 diabetes (28 y) · health professionals from the USA and participants (“healthy volunteers from the Biobank cohort”) from the UK
The intervention may leads to higher type 2 diabetes (28 y) (low certainty).
1 finding from 1 review
HR 1.14 [1.07, 1.22]
71766 participants
Low
Intervention not reported
Cardiovascular mortality · healthy normal weighted participants recruited through leaflets from Italy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Total VTE · people undergoing bariatric surgery
Higher‐dose heparin showed no clear difference in VTE compared with standard‐dose heparin (low certainty).
1 finding from 1 review